Cargando…
New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor
BACKGROUND: We previously showed that growth hormone-releasing hormone (GHRH) agonists are cardioprotective following myocardial infarction (MI). Here, our aim was to evaluate the in vitro and in vivo activities of highly potent new GHRH agonists, and elucidate their mechanisms of action in promotin...
Autores principales: | Kanashiro-Takeuchi, Rosemeire M., Szalontay, Luca, Schally, Andrew V., Takeuchi, Lauro M., Popovics, Petra, Jaszberenyi, Miklos, Vidaurre, Irving, Zarandi, Marta, Cai, Ren-Zhi, Block, Norman L., Hare, Joshua M., Rick, Ferenc G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496393/ https://www.ncbi.nlm.nih.gov/pubmed/25797248 |
Ejemplares similares
-
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone
por: Jaszberenyi, Miklos, et al.
Publicado: (2013) -
Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levels
por: Popovics, Petra, et al.
Publicado: (2014) -
Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease
por: Jaszberenyi, Miklos, et al.
Publicado: (2012) -
Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 (AEZS-108)
por: Szepeshazi, Karoly, et al.
Publicado: (2012) -
Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers
por: Perez, Roberto, et al.
Publicado: (2012)